Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:

A phase III partially double blinded study evaluating the efficacy and safety of 4okD branched pegylated inteferon alfa-2a (PEG-IGFN, Ro 25-8310) combined with placebo or lamivudine versus lamivudine in anti-HBe positive patients with chronic hepatitis B
peg-interferon alpha-2a
chronic hepatitis b
Phase 3
January 2014

Powered by ideaPoint, Inc.